Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Look to Norway! (But not uncritically).

A R Saetnan, B Backe, A Kolstad

    International Journal of Technology Assessment in Health Care
    |December 11, 1987
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Total body irradiation after high-dose cytarabine in mantle cell lymphoma: a comparison of Nordic MCL2, HOVON-45, and European MCL Younger trials.

    Leukemia·2015
    Same author

    The consistency of experts' evaluation of obstetric claims for compensation.

    BJOG : an international journal of obstetrics and gynaecology·2014
    Same author

    Prevalence and predictors of anal incontinence during pregnancy and 1 year after delivery: a prospective cohort study.

    BJOG : an international journal of obstetrics and gynaecology·2013
    Same author

    Dose-densified chemoimmunotherapy followed by systemic central nervous system prophylaxis for younger high-risk diffuse large B-cell/follicular grade 3 lymphoma patients: results of a phase II Nordic Lymphoma Group study.

    Annals of oncology : official journal of the European Society for Medical Oncology·2012
    Same author

    Ultra-short course sirolimus contributes to effective GVHD prophylaxis after reduced-intensity allogeneic hematopoietic cell transplantation.

    Bone marrow transplantation·2012
    Same author

    Two escalated followed by six standard BEACOPP in advanced-stage high-risk classical Hodgkin lymphoma: high cure rates but increased risk of aseptic osteonecrosis.

    Annals of oncology : official journal of the European Society for Medical Oncology·2011

    Norway's national health service is affordable and advanced, with equitable medical resource distribution. Further examination of health technologies and decision-making is recommended for optimization.

    Area of Science:

    • Health Services Research
    • Public Health Policy
    • Medical Technology Assessment

    Background:

    • Norway's national health service operates under a highly regulated system at national and local levels.
    • Distribution issues within the health service are often subjects of political discussion and debate.
    • Public perception of the Norwegian health service may not fully align with its operational realities.

    Purpose of the Study:

    • To evaluate the cost-effectiveness and technological advancement of Norway's national health service.
    • To assess the equity and distribution patterns of medical care and equipment in Norway.
    • To identify areas for improved examination of health technologies and decision-making processes.

    Main Methods:

    • Analysis of national health service data and regulatory frameworks.

    Related Experiment Videos

  • Review of medical resource distribution across different regions.
  • Examination of political discourse surrounding health service challenges.
  • Main Results:

    • The Norwegian national health service is characterized as inexpensive and technologically advanced.
    • Medical care and equipment are equitably, though potentially over-densely, distributed nationwide.
    • The system's regulation contributes to equitable distribution despite political debates on resource allocation.

    Conclusions:

    • Norway's health service demonstrates efficiency and equitable resource distribution.
    • There is a need for enhanced scrutiny of health technologies, priorities, and decision-making via expert consensus.
    • Continued evaluation through consensus conferences and technology assessment is advised for future improvements.